$9.13
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. The company is headquartered in New York City, New York and currently employs 5,600 full-time employees. The company went IPO on 2015-07-01. Its segments include Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed on a B2B basis. BetterHelp segment includes direct-to-consumer mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs. Its Telecare brand is a tech-enabled provider of specialist and allied health care via virtual delivery.
Country

US

CEO

Mr. Charles Divita

IPO date

2015

Employees

5,124

ISIN

US87918A1051

Key stats

Open

$9.12

Volume

3.00M

Market cap

$1.66B

Prev. close

$9.21

Impl / hst vl

-

Open interest

$0.00

$9.12

Day’s Range

$9.36

$4.40

52W Range

$9.68

Valuation

66
Valuation score
Undervalued
P/E
-
P/S
0.66
P/B
1.24
Current ratio
2.80
Debt / Equity
0.18
ROE
-12.37%
Gross margin
67.82%
Income growth
153.90%
FCF growth
-149.24

Analysts estimates

Consensus rating
Hold

The average rating from top 20 analysts indicates that stock may significantly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$7.40
The top 23 analysts forecasts that 12-month price may decrease by 19.00%, with a low of $5.05 and a high of $10.50
$5.05
Low
$7.40
Avg
$10.50
High
Current price

Earnings

Q1 ‘26 revenue
$613.85M
Q1 ‘26 net income
-$63.84M
Revenue
Net income
Previous EPS
-$0.36
Estimate EPS
-$0.25
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply